Article Abstract

Survival implications of transbronchial cryobiopsy and other diagnostic modalities in idiopathic pulmonary fibrosis

Authors: Jasleen K. Pannu, Justin C. Hewlett, Aaron B. Smith, Wendi R. Mason, Heidi Chen, Otis B. Rickman, Robert J. Lentz, Jonathan A. Kropski, Fabien Maldonado

Abstract

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive fibrotic lung disease with a median survival of only 2 to 3 years (1). Approximately half of IPF diagnoses are established by characteristic features on high resolution computerized tomographic scan of the chest (HRCT).